161 related articles for article (PubMed ID: 18302937)
1. Identification of E2F1 as a positive transcriptional regulator for delta-catenin.
Kim K; Oh M; Ki H; Wang T; Bareiss S; Fini ME; Li D; Lu Q
Biochem Biophys Res Commun; 2008 May; 369(2):414-20. PubMed ID: 18302937
[TBL] [Abstract][Full Text] [Related]
2. Human homolog of Drosophila Hairy and enhancer of split 1, Hes1, negatively regulates δ-catenin (CTNND2) expression in cooperation with E2F1 in prostate cancer.
Lu JP; Zhang J; Kim K; Case TC; Matusik RJ; Chen YH; Wolfe M; Nopparat J; Lu Q
Mol Cancer; 2010 Nov; 9():304. PubMed ID: 21106062
[TBL] [Abstract][Full Text] [Related]
3. delta-Catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profiles.
Zeng Y; Abdallah A; Lu JP; Wang T; Chen YH; Terrian DM; Kim K; Lu Q
Mol Cancer; 2009 Mar; 8():19. PubMed ID: 19284555
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of delta-catenin/neural plakophilin-related armadillo protein is associated with the down-regulation and redistribution of E-cadherin and p120ctn in human prostate cancer.
Lu Q; Dobbs LJ; Gregory CW; Lanford GW; Revelo MP; Shappell S; Chen YH
Hum Pathol; 2005 Oct; 36(10):1037-48. PubMed ID: 16226102
[TBL] [Abstract][Full Text] [Related]
5. Identification of extracellular delta-catenin accumulation for prostate cancer detection.
Lu Q; Zhang J; Allison R; Gay H; Yang WX; Bhowmick NA; Frelix G; Shappell S; Chen YH
Prostate; 2009 Mar; 69(4):411-8. PubMed ID: 19116988
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene.
Schayek H; Bentov I; Rotem I; Pasmanik-Chor M; Ginsberg D; Plymate SR; Werner H
Growth Horm IGF Res; 2010 Feb; 20(1):68-72. PubMed ID: 19703789
[TBL] [Abstract][Full Text] [Related]
7. Leupaxin acts as a mediator in prostate carcinoma progression through deregulation of p120catenin expression.
Kaulfuss S; von Hardenberg S; Schweyer S; Herr AM; Laccone F; Wolf S; Burfeind P
Oncogene; 2009 Nov; 28(45):3971-82. PubMed ID: 19701244
[TBL] [Abstract][Full Text] [Related]
8. Increased nucleotide polymorphic changes in the 5'-untranslated region of delta-catenin (CTNND2) gene in prostate cancer.
Wang T; Chen YH; Hong H; Zeng Y; Zhang J; Lu JP; Jeansonne B; Lu Q
Oncogene; 2009 Jan; 28(4):555-64. PubMed ID: 18978817
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of δ-catenin palmitoylation slows the progression of prostate cancer.
Wang B; Zhou R; Wu J; Kim H; Kim K
Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119741. PubMed ID: 38697304
[TBL] [Abstract][Full Text] [Related]
10. Expression of p120-catenin isoforms correlates with genomic and transcriptional phenotype of breast cancer cell lines.
Paredes J; Correia AL; Ribeiro AS; Schmitt F
Cell Oncol; 2007; 29(6):467-76. PubMed ID: 18032823
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas.
Kallakury BV; Sheehan CE; Winn-Deen E; Oliver J; Fisher HA; Kaufman RP; Ross JS
Cancer; 2001 Dec; 92(11):2786-95. PubMed ID: 11753952
[TBL] [Abstract][Full Text] [Related]
12. Co-downregulation of cell adhesion proteins alpha- and beta-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas.
Kallakury BV; Sheehan CE; Ross JS
Hum Pathol; 2001 Aug; 32(8):849-55. PubMed ID: 11521230
[TBL] [Abstract][Full Text] [Related]
13. E2F1 suppresses Wnt/β-catenin activity through transactivation of β-catenin interacting protein ICAT.
Wu Z; Zheng S; Li Z; Tan J; Yu Q
Oncogene; 2011 Sep; 30(37):3979-84. PubMed ID: 21532622
[TBL] [Abstract][Full Text] [Related]
14. Novel Oncogenic Transcription Factor Cooperation in RB-Deficient Cancer.
Mandigo AC; Shafi AA; McCann JJ; Yuan W; Laufer TS; Bogdan D; Gallagher L; Dylgjeri E; Semenova G; Vasilevskaya IA; Schiewer MJ; McNair CM; de Bono JS; Knudsen KE
Cancer Res; 2022 Jan; 82(2):221-234. PubMed ID: 34625422
[TBL] [Abstract][Full Text] [Related]
15. δ-Catenin promotes E-cadherin processing and activates β-catenin-mediated signaling: implications on human prostate cancer progression.
Kim H; He Y; Yang I; Zeng Y; Kim Y; Seo YW; Murnane MJ; Jung C; Lee JH; Min JJ; Kwon DD; Kim KK; Lu Q; Kim K
Biochim Biophys Acta; 2012 Apr; 1822(4):509-21. PubMed ID: 22261283
[TBL] [Abstract][Full Text] [Related]
16. δ-Catenin, a Wnt/β-catenin modulator, reveals inducible mutagenesis promoting cancer cell survival adaptation and metabolic reprogramming.
Nopparat J; Zhang J; Lu JP; Chen YH; Zheng D; Neufer PD; Fan JM; Hong H; Boykin C; Lu Q
Oncogene; 2015 Mar; 34(12):1542-52. PubMed ID: 24727894
[TBL] [Abstract][Full Text] [Related]
17. Presenilin-1 inhibits delta-catenin-induced cellular branching and promotes delta-catenin processing and turnover.
Kim JS; Bareiss S; Kim KK; Tatum R; Han JR; Jin YH; Kim H; Lu Q; Kim K
Biochem Biophys Res Commun; 2006 Dec; 351(4):903-8. PubMed ID: 17097608
[TBL] [Abstract][Full Text] [Related]
18. Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins.
Su S; Minges JT; Grossman G; Blackwelder AJ; Mohler JL; Wilson EM
J Biol Chem; 2013 Aug; 288(34):24809-24. PubMed ID: 23853093
[TBL] [Abstract][Full Text] [Related]
19. TFDP3 was expressed in coordination with E2F1 to inhibit E2F1-mediated apoptosis in prostate cancer.
Ma Y; Xin Y; Li R; Wang Z; Yue Q; Xiao F; Hao X
Gene; 2014 Mar; 537(2):253-9. PubMed ID: 24406621
[TBL] [Abstract][Full Text] [Related]
20. Dancing in and out of the nucleus: p120(ctn) and the transcription factor Kaiso.
Daniel JM
Biochim Biophys Acta; 2007 Jan; 1773(1):59-68. PubMed ID: 17050009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
